Evidence map›Paper›PMID 42502513›Full record

ArticleCureus2026

Early-Onset Colorectal and Gastric Adenocarcinomas in a Patient With a Heterozygous BLM p.E1317K Variant of Uncertain Significance.

Arti A Patel, Victor M Samperio, Henry T Tsai

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arti A PatelDepartment of Internal Medicine, Eisenhower Medical Center, Rancho Mirage, USA.
Victor M SamperioDepartment of Medicine, Eisenhower Medical Center, Rancho Mirage, USA.
Henry T TsaiDepartment of Hematology/Oncology, Eisenhower Medical Center, Rancho Mirage, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early-onset gastrointestinal malignancies may raise concerns for hereditary cancer susceptibility, although interpretation of rare germline variants identified through multigene testing remains challenging. We describe the case of a male patient diagnosed with stage IIIB mismatch repair-proficient sigmoid adenocarcinoma at age 29 who subsequently developed a poorly differentiated gastric adenocarcinoma five years later. Germline testing identified a heterozygous BLM p.E1317K variant of uncertain significance (VUS) and no other pathogenic germline alterations. Both tumors demonstrated microsatellite-stable, mismatch repair-proficient disease with low tumor mutational burden, and the patient's family history was notable for gastric cancer in his father, collectively raising concern for an underlying cancer predisposition. Although Bloom syndrome is associated with biallelic pathogenic BLM variants, the oncologic significance of heterozygous BLM alterations remains incompletely defined. This report highlights the interpretive challenges surrounding rare germline variants in patients with multiple early-onset gastrointestinal malignancies and underscores the need for further investigation into the potential role of selected heterozygous BLM variants in cancer susceptibility.

Indexed as

blm genecolorectal cancergastric cancer (gc)h pylorimicrosatellite stability

Identifiers

PMID42502513
PMCPMC13401060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.